Intuitive Surgical Inc (ISRG)vsPulse Biosciences Inc (PLSE)
ISRG
Intuitive Surgical Inc
$469.98
-0.41%
HEALTHCARE · Cap: $167.61B
PLSE
Pulse Biosciences Inc
$22.02
+3.43%
HEALTHCARE · Cap: $958.23M
Smart Verdict
WallStSmart Research — data-driven comparison
Intuitive Surgical Inc generates 11703040% more annual revenue ($10.06B vs $86,000). ISRG leads profitability with a 28.4% profit margin vs 0.0%. ISRG earns a higher WallStSmart Score of 62/100 (C+).
ISRG
Buy62
out of 100
Grade: C+
PLSE
Avoid16
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-78.8%
Fair Value
$262.88
Current Price
$469.98
$207.10 premium
Intrinsic value data unavailable for PLSE.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Strong operational efficiency at 30.2%
Safe zone — low bankruptcy risk
Large-cap with strong market position
Keeps 28 of every $100 in revenue as profit
18.8% revenue growth
Conservative balance sheet, low leverage
Areas to Watch
Expensive relative to growth rate
Trading at 9.4x book value
Premium valuation, high expectations priced in
Trading at 16.1x book value
0.0% revenue growth
0.0% earnings growth
Smaller company, higher risk/reward
Comparative Analysis Report
WallStSmart ResearchBull Case : ISRG
The strongest argument for ISRG centers on Operating Margin, Altman Z-Score, Market Cap. Profitability is solid with margins at 28.4% and operating margin at 30.2%. Revenue growth of 18.8% demonstrates continued momentum.
Bull Case : PLSE
The strongest argument for PLSE centers on Debt/Equity.
Bear Case : ISRG
The primary concerns for ISRG are PEG Ratio, Price/Book, P/E Ratio. A P/E of 59.9x leaves little room for execution misses.
Bear Case : PLSE
The primary concerns for PLSE are Price/Book, Revenue Growth, EPS Growth.
Key Dynamics to Monitor
ISRG profiles as a growth stock while PLSE is a value play — different risk/reward profiles.
PLSE carries more volatility with a beta of 1.78 — expect wider price swings.
ISRG is growing revenue faster at 18.8% — sustainability is the question.
ISRG generates stronger free cash flow (730M), providing more financial flexibility.
Bottom Line
ISRG scores higher overall (62/100 vs 16/100), backed by strong 28.4% margins and 18.8% revenue growth. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Intuitive Surgical Inc
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
Intuitive Surgical, Inc. is an American corporation that develops, manufactures, and markets robotic products designed to improve clinical outcomes of patients through minimally invasive surgery, most notably with the da Vinci Surgical System.
Pulse Biosciences Inc
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
Pulse Biosciences, Inc. is a bioelectrical medicine startup. The company is headquartered in Hayward, California.
Visit Website →Compare with Other MEDICAL INSTRUMENTS & SUPPLIES Stocks
Want to dig deeper into these stocks?